Unknown

Dataset Information

0

Abnormal plasma clot formation and fibrinolysis reveal bleeding tendency in patients with partial factor XI deficiency.


ABSTRACT: Individuals with factor XI (FXI) deficiency have a variable bleeding risk that cannot be predicted from plasma FXI antigen or activity. This limitation can result in under- or overtreatment of patients and risk of bleeding or thrombosis. Previously, plasma clot fibrinolysis assays showed sensitivity to bleeding tendency in a small cohort of patients with severe FXI deficiency. Here, we determined the ability of plasma clot formation, structure, and fibrinolysis assays to predict bleeding tendency in a larger, independent cohort of patients with severe and partial FXI deficiency. Patients were characterized as nonbleeders or bleeders based on bleeding after tonsillectomy and/or dental extraction before diagnosis of FXI deficiency. Blood was collected in the absence or presence of the contact pathway inhibitor corn trypsin inhibitor (CTI). Clotting was triggered in platelet-poor plasma with tissue factor, CaCl2, and phospholipids in the absence and presence of thrombomodulin or tissue plasminogen activator. Clot formation and fibrinolysis were assessed by turbidity and confocal microscopy. CTI-treated plasmas from bleeders showed significantly reduced clot formation and decreased resistance to fibrinolysis compared with plasmas from controls or nonbleeders. Differences were enhanced in the presence of CTI. A model that combines activated partial thromboplastin time with the rate of clot formation and area under the curve in fibrinolysis assays identifies most FXI-deficient bleeders. These results show assays with CTI-treated platelet-poor plasma reveal clotting and clot stability deficiencies that are highly associated with bleeding tendency. Turbidity-based fibrinolysis assays may have clinical utility for predicting bleeding risk in patients with severe or partial FXI deficiency.

SUBMITTER: Gidley GN 

PROVIDER: S-EPMC5965046 | biostudies-literature | 2018 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Abnormal plasma clot formation and fibrinolysis reveal bleeding tendency in patients with partial factor XI deficiency.

Gidley Gillian N GN   Holle Lori A LA   Burthem John J   Bolton-Maggs Paula H B PHB   Lin Feng-Chang FC   Wolberg Alisa S AS  

Blood advances 20180501 10


Individuals with factor XI (FXI) deficiency have a variable bleeding risk that cannot be predicted from plasma FXI antigen or activity. This limitation can result in under- or overtreatment of patients and risk of bleeding or thrombosis. Previously, plasma clot fibrinolysis assays showed sensitivity to bleeding tendency in a small cohort of patients with severe FXI deficiency. Here, we determined the ability of plasma clot formation, structure, and fibrinolysis assays to predict bleeding tendenc  ...[more]

Similar Datasets

| S-EPMC9140718 | biostudies-literature
| S-EPMC6474728 | biostudies-literature
| S-EPMC6851858 | biostudies-literature
| S-EPMC6736668 | biostudies-literature
| S-EPMC5567780 | biostudies-other
| S-EPMC6526940 | biostudies-literature
| S-EPMC7043730 | biostudies-literature
| S-EPMC7008283 | biostudies-literature
| S-EPMC9293080 | biostudies-literature
| S-EPMC5690612 | biostudies-literature